Eli Lilly (LLY) EVP Anat Hakim awarded 8,278 common shares in Form 4

Rhea-AI Filing Summary

Eli Lilly and Company executive Anat Hakim, EVP, GC & Secretary, reported an acquisition of common stock through a grant or award. On 02/09/2026, she acquired 8,277.919 shares of Eli Lilly common stock at $1,044.67 per share, bringing her directly held stake to 22,987.024 shares.

The filing also notes indirect holdings of 15,700 shares held by the Anat Hakim SLAT and 16,875 shares held by her spouse, with a disclaimer that she disclaims beneficial ownership of these securities except to the extent of her pecuniary interest.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hakim Anat

(Last) (First) (Middle)

LILLY CORPORATE CENTER

(Street)

INDIANAPOLIS IN 46285

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, GC & Secretary

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		A		8,277.919	A	$1,044.67	22,987.024	D
Common Stock								15,700	I	By Anat Hakim SLAT(1)
Common Stock								16,875	I	By spouse(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.

Remarks:

	/s/ Jonathan Groff for Anat Hakim, pursuant to authorization on file	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Eli Lilly (LLY) report for Anat Hakim?

Eli Lilly reported that EVP, GC & Secretary Anat Hakim acquired 8,277.919 shares of common stock via a grant or award on February 9, 2026. This increased her directly held stake to 22,987.024 Eli Lilly common shares after the reported transaction.

At what price was Anat Hakim’s Eli Lilly (LLY) stock grant recorded?

The stock grant to Anat Hakim was recorded at a price of $1,044.67 per Eli Lilly common share. This price is the transaction value reported for the 8,277.919 shares acquired through the grant or award on February 9, 2026.

How many Eli Lilly (LLY) shares does Anat Hakim hold directly after this Form 4?

After the reported grant, Anat Hakim directly holds 22,987.024 shares of Eli Lilly common stock. This figure reflects her direct ownership position following the 8,277.919-share award reported as acquired on February 9, 2026 in the insider filing.

What indirect Eli Lilly (LLY) holdings are associated with Anat Hakim?

The filing lists 15,700 Eli Lilly shares held by the Anat Hakim SLAT and 16,875 shares held by her spouse. Hakim disclaims beneficial ownership of these securities except to the extent of her pecuniary interest, as noted in the footnote to the Form 4.

What is Anat Hakim’s role at Eli Lilly (LLY) in this insider report?

In this insider report, Anat Hakim is identified as an officer of Eli Lilly with the title EVP, GC & Secretary. This role indicates she serves as executive vice president, general counsel, and secretary while being the reporting person for the disclosed stock grant.

Does the Form 4 state that Anat Hakim buys or sells Eli Lilly (LLY) stock on the market?

The Form 4 describes her transaction as a grant, award, or other acquisition of 8,277.919 shares, not an open-market buy or sale. The transaction code “A” indicates a grant or similar award rather than a market purchase or disposition of Eli Lilly stock.